|Bid||0.00 x 1000|
|Ask||0.00 x 900|
|Day's range||28.67 - 29.74|
|52-week range||26.00 - 55.22|
|Beta (5Y monthly)||1.46|
|PE ratio (TTM)||N/A|
|Earnings date||04 Aug 2020 - 10 Aug 2020|
|Forward dividend & yield||N/A (N/A)|
|1y target est||45.86|
Shares of cardiovascular-health company Shockwave Medical (NASDAQ: SWAV) fell on Thursday after the Patent Trial and Appeal Board ruled that two of its patents are invalid. Previously, fellow healthcare-company Cardiovascular Systems (NASDAQ: CSII) challenged two of Shockwave Medical's patents and asked the U.S. Patent and Trademark Office to look into it. The '371 patent adds a couple of electrodes inside a balloon catheter to help break up calcification in blood vessels.
CARDIOVASCULAR SYSTEMS, INC. TO PRESENT AT THE RAYMOND JAMES HUMAN HEALTH INNOVATION CONFERENCE
Shares of Cardiovascular Systems (NASDAQ: CSII) are down by 10.2% as of 1:00 p.m. EDT on Wednesday after the company announced the pricing of a public offering of common stock on Tuesday evening. Shares of Cardiovascular Systems were worth a little under $38.50 apiece at the close of market on Tuesday. Also, Cardiovascular Systems is giving underwriters the option to purchase an additional 551,470 shares within 30 days.
Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII) will host a live webcast of its fiscal 2020 third-quarter conference call on Tuesday, May 5, 2020.
Beta Bionics, Inc. — a medical technology company developing and aiming to commercialize the world’s first fully automated bionic pancreas system called the iLet® today announced that Martha G. Aronson and Sean D. Carney have been appointed to the Company’s Board of Directors effective immediately.
If you own shares in Cardiovascular Systems, Inc. (NASDAQ:CSII) then it's worth thinking about how it contributes to...
Cardiovascular Systems (CSII) delivered earnings and revenue surprises of -233.33% and 0.65%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Cardiovascular Systems (CSII) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
If you want to compound wealth in the stock market, you can do so by buying an index fund. But you can significantly...
Cardiovascular Systems (CSII) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
We are upbeat about the year-over-year uptick in both Coronary and peripheral device revenues within Cardiovascular Systems' (CSII) domestic market.
Cardiovascular Systems (CSII) delivered earnings and revenue surprises of -88.89% and 0.72%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
We often see insiders buying up shares in companies that perform well over the long term. Unfortunately, there are...
Anyone researching Cardiovascular Systems, Inc. (NASDAQ:CSII) might want to consider the historical volatility of the...
This study outcome is expected to be a major stride forward in Cardiovascular Systems' (CSII) endeavor to offer treatment to patients of multi-level peripheral artery disease (PAD).
We are upbeat about the year-over-year uptick in Coronary and peripheral device revenues within Cardiovascular Systems' (CSII) domestic market.